Knocking out CX3CR1 reduced neuron loss [91] and amyloid-beta deposition [92] in Alzheimer's disease mouse models, and interfered with formation of thalamocortical synapses during development, when fractalkine is overexpressed. The gene discussed is CX3CL1; the disease is early-onset autosomal dominant Alzheimer disease.